News - Biotechnology
Progressing the long-term plan for stem cell research
The Morrison Government is pleased to announce the next step in the $150 million Stem Cell Therapies Mission, with the release of the draft Roadmap for public consultation, which will help guide this 10-year investment in medical research.
The Mission is an opportunity for world-class Australian researchers to further investigate an area which presents significant opportunities for new medical treatments for many chronic and inherited diseases.
Australia is a global leader in stem cell science, with more 300 research laboratories focused on regenerative medicine and cell therapy.
Research advances over the last decade have shown the potential of stem cells to restore function to damaged tissues, engineer replacement tissues and organs and boost the body’s ability to heal itself.
Human stem cells can also be used in the lab to better understand what happens to the body during disease and to test new drugs without any risk to patients.

Differentiate your organisation and amplify your brand value proposition to our 8,500+ industry professionals. Health Industry Hub offers a wealth of content in a one-stop-hub to connect and engage Pharma, MedTech and Biotech industry professionals. Ask us how.
The Stem Cell Therapies Mission will support Australia’s talented researchers to further investigate what is possible through stem cell therapies.
The first grant opportunities under the Stem Cell Therapies Mission will begin in the coming months.
A Stem Cell Therapies Expert Advisory Panel has been selected to guide the Mission, and apply its experience and expertise to drafting the Roadmap.
The Morrison Government is funding the mission through its $20 billion Medical Research Future Fund—the single largest boost in health and medical research funding in Australia’s history.
The MRFF supports our world-class Australian researchers to make discoveries, develop a global biotech industry and enable the implementation of significant changes in health care.
For more information on the roadmap, and to provide feedback, visit https://consultations.health.gov.au/health-economics-and-research-division/mrff-stem-cell-therapies-mission
You may also like Multi-cancer blood test expands data in over 20 disease types
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More